For its second fiscal quarter (ending June 30), Exelixis Inc (NASDAQ: EXEL) has reported a 212% increase in E.P.S. from $0.25 a year ago to $0.78 in the current quarter. This performance was $0.41 better than the consensus estimate of $0.37. E.P.S. were $1.17 for the latest four quarters through June 30 versus $0.51 for the same period a year ago — an increase of 129%.
Recent Price Action
Exelixis Inc (NASDAQ: EXEL) stock declined slightly by -0.3% on 8/6/24. The stock closed at $23.45. Trading volume in this decline was normal. The stock has risen 1.5% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
EXEL’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Exelixis has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Exelixis has a neutral Appreciation Score of 44 and a slightly negative Power Rating of 37, triggering the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment